DK4481A - Hydroxyalkylstivelse som laegemiddelbaerer - Google Patents

Hydroxyalkylstivelse som laegemiddelbaerer

Info

Publication number
DK4481A
DK4481A DK4481A DK4481A DK4481A DK 4481 A DK4481 A DK 4481A DK 4481 A DK4481 A DK 4481A DK 4481 A DK4481 A DK 4481A DK 4481 A DK4481 A DK 4481A
Authority
DK
Denmark
Prior art keywords
hydroxyal
starches
cool
medicinal carriers
medicinal
Prior art date
Application number
DK4481A
Other languages
English (en)
Other versions
DK155078C (da
DK155078B (da
Inventor
K L Berger
J M Brake
F H Deindoerfer
C S Bankert
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of DK4481A publication Critical patent/DK4481A/da
Publication of DK155078B publication Critical patent/DK155078B/da
Application granted granted Critical
Publication of DK155078C publication Critical patent/DK155078C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/14Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/05Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
    • C08B15/06Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur containing nitrogen, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK004481A 1979-05-10 1981-01-07 Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse DK155078C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3798179A 1979-05-10 1979-05-10
US3798179 1979-05-10
US8000527 1980-05-08
PCT/US1980/000527 WO1980002374A1 (en) 1979-05-10 1980-05-08 Hydroxyalkyl starch drug carrier

Publications (3)

Publication Number Publication Date
DK4481A true DK4481A (da) 1981-01-07
DK155078B DK155078B (da) 1989-02-06
DK155078C DK155078C (da) 1989-07-10

Family

ID=21897414

Family Applications (1)

Application Number Title Priority Date Filing Date
DK004481A DK155078C (da) 1979-05-10 1981-01-07 Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse

Country Status (10)

Country Link
EP (2) EP0019403B1 (da)
JP (1) JPH0140812B2 (da)
KR (1) KR840001798B1 (da)
AT (1) ATE12892T1 (da)
CA (1) CA1158159A (da)
DE (1) DE3070546D1 (da)
DK (1) DK155078C (da)
ES (1) ES8105145A1 (da)
NZ (1) NZ193618A (da)
WO (1) WO1980002374A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
DE3421954C1 (de) * 1984-06-13 1985-10-24 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Diätetisches Nährmittel, enthaltend Hydroxyethylstärke
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10209822A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
ES2214166T1 (es) * 2002-09-11 2004-09-16 Fresenius Kabi Deutschland Gmbh Polipeptidos has-ilados, especialmente, eriptropoyetina has-ilada.
KR101174510B1 (ko) 2002-09-11 2012-08-16 프레제니우스 카비 도이치란트 게엠베하 하이드록시알킬전분화 폴리펩티드, 특히 하이드록시알킬전분화 에리트로포이에틴
DE60323756D1 (de) 2002-10-08 2008-11-06 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
DE10256558A1 (de) * 2002-12-04 2004-09-16 Supramol Parenteral Colloids Gmbh Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
EP2336192A1 (en) 2004-03-11 2011-06-22 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
GB0811743D0 (en) 2008-06-26 2008-07-30 Hemosol Biopharma Inc Composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1167794B (de) * 1953-09-03 1964-04-16 Corn Products Company Eine Ges Verfahren zum Einbetten wasserunloeslicher Vitamine und anderer bei der Aufbewahrung sich verschlechternder oder verdampfender Stoffe in eine Umhuellung
US3523938A (en) 1967-12-13 1970-08-11 American Hospital Supply Corp Starch plasma expanders and process of preparation
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
US3928581A (en) * 1972-09-13 1975-12-23 Astra Laekemedel Ab Certain polymer-iron complexes for treatment of iron deficiency
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE2829037A1 (de) * 1978-07-01 1980-01-10 Fresenius Chem Pharm Ind Wasserloesliche, keimtoetende mittel enthaltende mund- und rachenpflegemittel
DE2838736A1 (de) * 1978-09-06 1980-03-20 Theodor Prof Dr Eckert Verwendung von hydroxyaethylstaerke als pudergrundlage
JPS6348545A (ja) * 1986-08-18 1988-03-01 Nippon Zeon Co Ltd 感光性フレキソ版用エラストマ−組成物

Also Published As

Publication number Publication date
KR830002510A (ko) 1983-05-30
DK155078C (da) 1989-07-10
KR840001798B1 (ko) 1984-10-20
ATE12892T1 (de) 1985-05-15
ES491307A0 (es) 1981-05-16
EP0028641A1 (en) 1981-05-20
ES8105145A1 (es) 1981-05-16
WO1980002374A1 (en) 1980-11-13
JPH0140812B2 (da) 1989-08-31
EP0019403A3 (en) 1981-10-07
EP0019403B1 (en) 1985-07-31
NZ193618A (en) 1984-07-06
EP0019403A2 (en) 1980-11-26
EP0028641B1 (en) 1985-04-24
DK155078B (da) 1989-02-06
EP0028641A4 (en) 1981-09-01
CA1158159A (en) 1983-12-06
DE3070546D1 (de) 1985-06-05
JPS56500495A (da) 1981-04-16

Similar Documents

Publication Publication Date Title
DK4481A (da) Hydroxyalkylstivelse som laegemiddelbaerer
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
OA06063A (fr) Dérivés de l'anthelmintique C-076.
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
ES458967A1 (es) Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.
GB2021409A (en) Pharmaceutical composition
ATE14015T1 (de) Oxazolderivate, ihre herstellung und ihre verwendung.
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO154131C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat
OA04571A (fr) Préparation et utilisation des dérivés d'a-pyrone.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью
JPS5432482A (en) 3,4-dihydrocarbostyril derivatives and bactericides containing the same as active agnet for agricultural and horticultural uses
JPS53124264A (en) Benzoxazolone derivatives, their preparation, and bactericides for agricultural and horticultural uses containing the same active agent
SU701101A1 (ru) Производные 2-х-бензилиденгидразино-4-фенил-5n-r- сульфамоилфенилазотиазола, обладающие акарицидной активностью